Bones have a natural tendency to heal, however if the defect surpasses a critical size, then bone grafting is the preferred option. Bone grafting is a surgical procedure that replaces the missing or damaged bone by natural or synthetic bone. There are three major types of bone grafts: autografts, allografts, and bone substitutes. Bone grafts and substitutes should be biocompatible, osteoconductive, osteoinductive, structurally similar to bone, easy to use, and cost effective. Autogenous bone grafts contain osteoblast and endosteal osteoprogenitor cells for regenerating the new bone. Although autografts are considered gold standard for bone grafting, major disadvantages associated with autografts are limited supply and high donor site morbidity rate.
The bone grafts and substitutes (BGS) market report studies the current scenario as well as future market potential for bone grafts and substitutes globally. The market overview section of the report comprises qualitative analysis of the overall BGS market considering the factors determining the market dynamics such as drivers, restraints, and opportunities, along with Porter’s Five Forces analysis and market attractiveness analysis by geography. In addition, various analyses such as event impact analysis and market share analysis by key players have been provided in the bone graft and substitutes market report.
The global BGS market has been segmented based on type, application, and geography. Based on type, the global BGS market has been categorized into allografts and bone substitutes. The allografts segment has been sub-segmented into demineralized bone matrix (DBM) and others. The bone graft substitutes segment is further segmented into synthetic bone grafts, bone morphogenetic protein (BMP), and others. Based on application, the BGS market has been classified into spinal fusion, long bone, foot and ankle, craniomaxillofacial surgery (CMF), dental, and joint reconstruction. The market for these types and applications has been extensively analyzed on the basis of factors such as product approval date, product demand, sales revenue, geographic presence, and product features. The market size and forecast in terms of revenue (USD million) for each of these segments have been provided for the period from 2013 to 2023, considering 2013 and 2014 as the base years. The report also provides the compound annual growth rate (CAGR) for each segment for the forecast period from 2015 to 2023.
Geographically, the BGS market has been classified into five major regions: North America, Europe, Asia Pacific, Latin America, and Rest of the World (RoW). The market size and forecast for each region have been provided for the period from 2013 to 2023, along with the CAGR (%) for the forecast period from 2015 to 2023.
A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market shares. The report concludes with the profiles of major players in the global BGS market such as The DePuy Synthes Companies, Zimmer Biomet Holdings, Inc., Baxter International, Inc., Medtronic plc, Stryker Corporation, Wright Medical Technology Inc., AlloSource, NuVasive Inc., and Orthofix Holdings, Inc. The major market players have been assessed on various parameters such as company overview, financial overview, product portfolio, business strategies, and recent developments.
The global bone grafts and substitutes market has been segmented as follows:
Global Bone Grafts and Substitutes Market, by Type
- Demineralised Bone Matrix
- Bone Graft Substitutes
- Bone Morphogenic Proteins (BMP)
Global Bone Grafts and Substitutes Market, by Application
- Spinal Fusion
- Long Bone
- Foot and Ankle
- Joint Reconstruction
Global Bone Grafts and Substitutes Market, by Geography